Topic: Manufacturing Facilities
Boehringer Ingelheim has invested €225 million on inhaler production with a new plant in Spain and expanded lines in Germany.
Just weeks after a stinging report was delivered to Aurobindo’s sterile drug plant in Telangana, the FDA has blasted a finished drug facility there.
An explosion at a pharmaceutical manufacturing facility has again claimed the lives of workers.
Aldevron unveiled plans to expand its North Dakota headquarters into a 14-acre campus.
German CDMO Vetter says all of its nine German sites are now powered by energy from certified renewable energy sources.
Dendreon has signaled faith in its struggling prostate drug Provenge by signing a 10-year lease extension for its California manufacturing facility.
WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.
Catalent's newly acquired Paragon Bioservices will expand its capacity to as much as 425,000 square feet to manufacture therapies for Sarepta.
GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.
Novartis may be struggling a bit in the U.S. with cancer drug launches, but it has a new market it can now explore: Saudi Arabia.